SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001104659-23-109317
Filing Date
2023-10-16
Accepted
2023-10-16 13:58:09
Documents
1
Effectiveness Date
2023-10-16

Document Format Files

Seq Description Document Type Size
1 S-8 POS tm2328498d6_s8pos.htm S-8 POS 29573
  Complete submission text file 0001104659-23-109317.txt   30684
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-219387 | Film No.: 231327085
SIC: 2834 Pharmaceutical Preparations